{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:15:53Z","timestamp":1782274553847,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"am","delay-in-days":415,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1R01EB014284"],"award-info":[{"award-number":["1R01EB014284"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"COBRE","award":["1P20GM109025-01A1"],"award-info":[{"award-number":["1P20GM109025-01A1"]}]},{"name":"Elaine P Wynn and Family Foundation"},{"name":"Sam and Peggy Grossman Foundation"},{"name":"Samuel P. Mandell Foundation"},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014392","name":"Avid Radiopharmaceuticals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006314","name":"Biogen Idec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Meyers Squibb","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Covance"},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013327","name":"Lundbeck","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Piramal Imaging"},{"name":"Roche CNS group"},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCB"},{"name":"Golub Capital"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.parkreldis.2019.02.001","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T07:55:55Z","timestamp":1549785355000},"page":"3-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Altered functional network topology correlates with clinical measures in very early-stage, drug-na\u00efve Parkinson's disease"],"prefix":"10.1016","volume":"62","author":[{"given":"Karthik","family":"Sreenivasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0452-6400","authenticated-orcid":false,"given":"Virendra","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengshi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Cordes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan R.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2019.02.001_bib1","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2019.02.001_bib2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.31887\/DCNS.2004.6.3\/galexander","article-title":"Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder","volume":"6","author":"Alexander","year":"2004","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.parkreldis.2019.02.001_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-016-0066-0","article-title":"The study of brain functional connectivity in Parkinson's disease","volume":"5","author":"Gao","year":"2016","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.parkreldis.2019.02.001_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cortex.2015.08.005","article-title":"A systematic review on the applications of resting-state fMRI in Parkinson's disease: does dopamine replacement therapy play a role?","volume":"73","author":"Tahmasian","year":"2015","journal-title":"Cortex"},{"key":"10.1016\/j.parkreldis.2019.02.001_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.trci.2018.04.009","article-title":"Advances in functional magnetic resonance imaging data analysis methods using Empirical Mode Decomposition to investigate temporal changes in early Parkinson's disease","author":"Cordes","year":"2018","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.parkreldis.2019.02.001_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuroimage.2018.01.019","article-title":"Incorporating spatial constraint in co-activation pattern analysis to explore the dynamics of resting-state networks: an application to Parkinson's disease","volume":"172","author":"Zhuang","year":"2018","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2019.02.001_bib7","doi-asserted-by":"crossref","first-page":"9239","DOI":"10.1523\/JNEUROSCI.1929-08.2008","article-title":"Hierarchical organization of human cortical networks in health and schizophrenia","volume":"28","author":"Bassett","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.parkreldis.2019.02.001_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nrn2575","article-title":"Complex brain networks: graph theoretical analysis of structural and functional systems","volume":"10","author":"Bullmore","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.parkreldis.2019.02.001_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1523\/JNEUROSCI.3874-05.2006","article-title":"A resilient, low-frequency, small-world human brain functional network with highly connected association cortical hubs","volume":"26","author":"Achard","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.parkreldis.2019.02.001_bib10","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1002\/hbm.22499","article-title":"Functional brain networks and cognitive deficits in Parkinson's disease","volume":"35","author":"Baggio","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.parkreldis.2019.02.001_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.601","article-title":"Increased thalamic centrality and putamen\u2013thalamic connectivity in patients with parkinsonian resting tremor","volume":"7","author":"Gu","year":"2017","journal-title":"Brain Behav"},{"key":"10.1016\/j.parkreldis.2019.02.001_bib12","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1148\/radiol.2017162929","article-title":"Functional brain connectome and its relation to hoehn and yahr stage in Parkinson disease","volume":"285","author":"Suo","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.parkreldis.2019.02.001_bib13","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00415-015-7750-3","article-title":"Functional connectome assessed using graph theory in drug-naive Parkinson's disease","volume":"262","author":"Luo","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2019.02.001_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2018.06.021","article-title":"Impaired topographic organization in cognitively unimpaired drug-na\u00efve patients with rigidity-dominant Parkinson's disease","author":"Hou","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.02.001_bib15","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement disorder society UPDRS revision task force, movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.02.001_bib16","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.neuroimage.2010.09.028","article-title":"Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects","volume":"54","author":"Mure","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2019.02.001_bib17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/hbm.23260","article-title":"Parkinson's disease-related network topographies characterized with resting state functional MRI","volume":"38","author":"Vo","year":"2017","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.parkreldis.2019.02.001_bib18","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/mds.22870","article-title":"Imaging essential tremor","volume":"25","author":"Isaias","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.02.001_bib19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.neuroimage.2015.01.057","article-title":"Introducing co-activation pattern metrics to quantify spontaneous brain network dynamics","volume":"111","author":"Chen","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2019.02.001_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2019.02.001_bib21","first-page":"386","article-title":"GRETNA: a graph theoretical network analysis toolbox for imaging connectomics","volume":"9","author":"Wang","year":"2015","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.parkreldis.2019.02.001_bib22","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1371\/journal.pcbi.0030017","article-title":"Efficiency and cost of economical brain functional networks","volume":"3","author":"Achard","year":"2007","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.parkreldis.2019.02.001_bib23","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1523\/JNEUROSCI.0141-08.2008","article-title":"Structural insights into aberrant topological patterns of large-scale cortical networks in Alzheimer{\\textquoteright}s disease","volume":"28","author":"He","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.parkreldis.2019.02.001_bib24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/30918","article-title":"Collective dynamics of \u2018small-world\u2019 networks","volume":"393","author":"Watts","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.parkreldis.2019.02.001_bib25","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.neuroimage.2009.10.003","article-title":"Complex network measures of brain connectivity: uses and interpretations","volume":"52","author":"Rubinov","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2019.02.001_bib26","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.neuroimage.2011.01.017","article-title":"Resting state fMRI reveals increased subthalamic nucleus\u2013motor cortex connectivity in Parkinson's disease","volume":"55","author":"Baudrexel","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.parkreldis.2019.02.001_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2019.02.001_bib28","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/mds.22680","article-title":"Temporal lobe changes in early, untreated Parkinson's disease","volume":"24","author":"Martin","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.02.001_bib29","doi-asserted-by":"crossref","first-page":"R868","DOI":"10.1016\/j.cub.2007.08.005","article-title":"The amygdala","volume":"17","author":"LeDoux","year":"2007","journal-title":"Curr. Biol."},{"key":"10.1016\/j.parkreldis.2019.02.001_bib30","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.neurobiolaging.2007.02.002","article-title":"Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson's disease","volume":"29","author":"Bouchard","year":"2008","journal-title":"Neurobiol. Aging"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380201930032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380201930032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:15:21Z","timestamp":1761178521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135380201930032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":30,"alternative-id":["S135380201930032X"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.02.001","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered functional network topology correlates with clinical measures in very early-stage, drug-na\u00efve Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}